Ignite Creation Date:
2024-07-17 @ 11:58 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06464939
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-18
First Post:
2024-06-13
Brief Title:
Phase 2 Study of KH001 in Long-term Relief From Dentin Hypersensitivity
Sponsor:
HysensBio Co Ltd
Organization:
HysensBio Co Ltd
Study Overview
Official Title:
A Randomized Double-blinded Placebo-controlled Phase 2 Study to Assess the Efficacy and Safety of Three Topical Applications of KH001 in Providing Long-term Relief From Dentin Hypersensitivity
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the efficacy and safety of KH001 in subjects with dentin hypersensitivity
Detailed Description:
The study will consist of a screening period a treatment period and a follow-up period The total duration of the study for each subject will be approximately 8 to 12 weeks All subjects will be randomly assigned in a 111 ratio with Group A Group B and Group C
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None